Quest 10 Wealth Builders’s Royalty Pharma RPRX Stock Holding History

Quest 10 Wealth Builders’s Portfolio RPRX Stock Details RPRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$7.96K	Buy	+142	New	+$7.39K	0.01%	486
2026 Q1	–	Sell	-141	Closed	-$5.45K	–	839
2025 Q4	$5.45K	Hold	141	–	–	﹤0.01%	488
2025 Q3	$4.97K	Sell	141 -224	-61%	-$8.11K	﹤0.01%	495
2025 Q2	$13.2K	Hold	365	–	–	0.01%	358
2025 Q1	$11.4K	Hold	365	–	–	0.01%	351
2024 Q4	$9.31K	Buy	+365	New	+$9.68K	0.01%	402

Other funds holding RPRX

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Quest 10 Wealth Builders's RPRX Position: Q2 2026 in Review

Quest 10 Wealth Builders opened a new position in Royalty Pharma (RPRX) in Q2 2026: 142 shares worth $7.96K. The stake represents 0.01% of the portfolio and ranks #486 among its holdings. This is a return to the name: Quest 10 Wealth Builders previously reported a position in RPRX as recently as Q4 2025.

Quest 10 Wealth Builders first reported a position in RPRX in Q4 2024 and has held it in 6 quarters since. The position peaked at $13.2K in Q2 2025. 645 funds tracked by Wall St. Rank hold RPRX as of Q2 2026.

Quest 10 Wealth Builders held 142 shares of Royalty Pharma worth $7.96K as of Q2 2026.
Royalty Pharma was a new Quest 10 Wealth Builders position in Q2 2026.
Royalty Pharma made up 0.01% of Quest 10 Wealth Builders's portfolio in Q2 2026, its #486 holding.
Quest 10 Wealth Builders first reported a position in Royalty Pharma in Q4 2024 and has held it in 6 quarters since.
Quest 10 Wealth Builders's Royalty Pharma position peaked at $13.2K in Q2 2025.
645 funds tracked by Wall St. Rank held Royalty Pharma as of Q2 2026.

Based on Quest 10 Wealth Builders's 13F filing for Q2 2026, filed 24 Jul 2026.